Think about the possible implications of the following statement.

"A Phase 2 proof of concept trial for ulcerative proctitis is planned in Q1 2016. We are excited to be pushing forward with this trial earlier than expected.

They get to decide when to begin so very likely this bodes well for B- om

http://cellceutix.com/best-yet-to-come/#sthas...ZmzAm.dpbs

$ctix